Key information

🔎 Fund Overview

LivaNova PLC is a global medical device company. The Company designs, develops, manufactures, and sells products and therapies to provide improvements for both the head and heart. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the development, production and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannulae and other related accessories. The Neuromodulation segment is engaged in the design, development, and marketing of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the LivaNova Vagus Nerve Stimulation Therapy (VNS Therapy) System, is an implantable device for the treatment of DRE and DTD. The ACS segment is engaged in the development, production, and sale of temporary life support products.